Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Van Hasselt

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|June 18, 2026
A novel hollow-fiber infection model (HFIM) for antiviral PK/PD studies of CMV infectionLalitya M Sudarsono, Suzanne A M Wenker, Xuanlin Liu, et al.
Radiology|March 3, 2004
Necrosis in metastatic neck nodes: diagnostic accuracy of CT, MR imaging, and USAnn D King, Gary M K Tse, Anil T Ahuja, et al.
Clinical Radiology|April 27, 2005
Human cervical lymphadenopathy: evaluation with in vivo 1H-MRS at 1.5 TA D King, D K Yeung, A T Ahuja, et al.
Journal of Psychopharmacology (Oxford, England)|September 7, 2010
Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteersG J H Dumont, J G C van Hasselt, M de Kam, et al.
European Journal of Radiology|March 31, 2005
In vivo 1H MR spectroscopy of thyroid carcinomaAnn D King, David K W Yeung, Anil T Ahuja, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 22, 2013
Development of a framework for cohort simulation in cost-effectiveness analyses using a multistep ordinary differential equation solver algorithm in RGerardus W J Frederix, Johan G C van Hasselt, Johan L Severens, et al.
Pharmacoeconomics|November 23, 2013
The impact of structural uncertainty on cost-effectiveness models for adjuvant endocrine breast cancer treatments: the need for disease-specific model standardization and improved guidanceGerardus W J Frederix, Johan G C van Hasselt, Jan H M Schellens, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 23, 2026
Defining the unbound target exposure of teicoplanin part 1: Insights from the Hollow-Fibre SystemJ W A Mouton, J Raaijmakers, S T Tandar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 10, 2014
Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxelJ G C van Hasselt, K van Calsteren, L Heyns, et al.
Clinical Pharmacokinetics|June 23, 2023
Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic DrugsJ M Janssen, D Damoiseaux, J G C van Hasselt, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|June 18, 2026
A novel hollow-fiber infection model (HFIM) for antiviral PK/PD studies of CMV infectionLalitya M Sudarsono, Suzanne A M Wenker, Xuanlin Liu, et al.
Radiology|March 3, 2004
Necrosis in metastatic neck nodes: diagnostic accuracy of CT, MR imaging, and USAnn D King, Gary M K Tse, Anil T Ahuja, et al.
Clinical Radiology|April 27, 2005
Human cervical lymphadenopathy: evaluation with in vivo 1H-MRS at 1.5 TA D King, D K Yeung, A T Ahuja, et al.
Journal of Psychopharmacology (Oxford, England)|September 7, 2010
Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteersG J H Dumont, J G C van Hasselt, M de Kam, et al.
European Journal of Radiology|March 31, 2005
In vivo 1H MR spectroscopy of thyroid carcinomaAnn D King, David K W Yeung, Anil T Ahuja, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 22, 2013
Development of a framework for cohort simulation in cost-effectiveness analyses using a multistep ordinary differential equation solver algorithm in RGerardus W J Frederix, Johan G C van Hasselt, Johan L Severens, et al.
Pharmacoeconomics|November 23, 2013
The impact of structural uncertainty on cost-effectiveness models for adjuvant endocrine breast cancer treatments: the need for disease-specific model standardization and improved guidanceGerardus W J Frederix, Johan G C van Hasselt, Jan H M Schellens, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 23, 2026
Defining the unbound target exposure of teicoplanin part 1: Insights from the Hollow-Fibre SystemJ W A Mouton, J Raaijmakers, S T Tandar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 10, 2014
Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxelJ G C van Hasselt, K van Calsteren, L Heyns, et al.
Clinical Pharmacokinetics|June 23, 2023
Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic DrugsJ M Janssen, D Damoiseaux, J G C van Hasselt, et al.
Pageof 9